PFSA Total Utang marang Modal Profusa, Inc

Profusa Inc (PFSA) relies on a staff of top-tier electronics developers and engineers, successfully avoiding labor shortages. The company's strategy is based on partnerships with the defense sector and research centers to implement implants. This chart of the total debt-to-equity ratio history on GURU.Markets shows 0.00. The business generates revenue by creating automated biosensors that transmit glucose and oxygen data directly to smartphones.

Profusa - Utang marang Modal PFSA (periode 15.07.2025 - 28.10.2026)

Rincian metrik komprehensif lan analitis Profusa, Inc (PFSA)

- rega lan prakiraan konsensus rega:
Kutipan saham Profusa|PFSA - Rega prakiraan analis
- data kapitalisasi pasar:
Kapitalisasi pasar Profusa|PFSA - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Nilai Buku saben Saham Profusa|PFSA - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku profusa.com|PFSA - Nilai Agregat Aset
- data utang lan likuiditas:
Total Utang marang Modal Profusa Inc|PFSA - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Profusa Inc|PFSA - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku Profusa|PFSA - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Profusa
Analisis dhasar perusahaan:Profusa PFSA

When selecting assets with a high margin of fundamental strength, it is critical to evaluate the financing structure through the balance of debt and equity. This indicator measures the business's degree of dependence on creditors, which for Profusa Inc. (PFSA) confirms financial stability while maintaining a costly engineering staff and biosensor experts, clearly reflecting the ratio of total liabilities to equity.

Analisis perusahaan pesaing

Dexcom (DXCM) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Penumbra Inc|Novanta Corp (NOVT) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Haemonetics Company (HAE)|INSP: Total Utang marang Modal|procept-biorobotics.com - Utang marang Modal|Utang marang Ekuitas CONMED (CNMD)|PLSE - Rasio Kabeh Utang marang Dana Pribadi|INMD: Total Utang marang Modal|PMI (Picard Group) - Total Utang marang Modal|Utang marang Ekuitas Surmodics, Inc. SRDX|Utang Agregat marang Ekuitas Senseonics Corp|NeuroPace - Total Utang marang Modal|Utang marang Modal tactilemedical.com TCMD|Rasio Total Utang marang Ekuitas SNWV (SANUWAVE Health, Inc.)|OM - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Electromed Inc ELMD|LNSR - Utang Agregat marang Modal|AVITA Medical - Total Utang marang Modal|Profound Medical (PROF) - Koefisien Total Utang marang Modal|Total Utang marang Modal BDMD|Rasio Total Utang marang Ekuitas EDAP Medical (EDAP)|Apyx Medical (APYX) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ICCM (icecure-medical.com)|Pulmonx - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas TELA Bio Inc. TELA|CTSO (CytoSorbents Corp.) - Total Utang marang Modal|SRTS - Utang marang Modal|Total Utang marang Modal Zynex, Inc.|electroCore (ECOR) - Rasio Utang marang Ekuitas|RBOT: Total Utang marang Modal|Koefisien Total Utang marang Modal Inspira Technologies Oxy B.H.N. Ltd|Total Utang marang Modal ICU (SeaStar Medical Holding Corp)|Rasio Total Utang marang Ekuitas iridex.com (IRIX)|Total Utang marang Modal INBS (Intelligent Bio Solutions Inc.)|Beyond Air Inc - Total Utang marang Modal|SSKN - Utang marang Ekuitas|glucotrack.com (GCTK) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas NanoVibronix NAOV|Venus Concept Corporation (VERO) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal NUWE (Nuwellis, Inc.)|Utang marang Modal AEMD|ASXC: Utang marang Ekuitas|Rasio Utang marang Modal Avinger Inc. AVGR|Rasio Total Utang marang Ekuitas BSGM (BioSig Technologies, Inc.)|Total Utang marang Modal Cutera Inc CUTR|Total Utang marang Modal KNW (Know Labs, Inc.)|NARI: Koefisien Total Utang marang Modal|Utang marang Ekuitas Nevro (NVRO)|RSLS (ReShape Lifesciences Inc.) - Utang Agregat marang Ekuitas|Utang marang Ekuitas SILK